SSY Groups (HKG:2005) attributable profit fell 20% to HK$1.06 billion in 2024 from HK$1.32 billion in 2023, according to a Friday filing with the Hong Kong bourse.
Earnings per share at the drug company decreased to HK$0.3581 from HK$0.4426 in the previous year.
Revenue declined 11% to HK$5.77 billion from HK$6.46 billion a year earlier.
The company declared a final dividend of HK$0.095 per share, payable June 3 to shareholders on record as of May 21.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.